header
Image from OpenLibrary

Fludarabine and Cyclophosphamide Versus COP As First Line Treatment In Chronic Lymphocytic Leukemia Patients / Nevein Farouk Francis ; Supervised Nasr Mohamed Ali , Azza Mahmoud Kamel , Thoraya Mohamed Abd El hamid

By: Contributor(s): Language: Eng Publication details: Cairo : Nevein Farouk Francis , 2006Description: 200P : charts ; 25cmOther title:
  • مقارنة العلاج الكميائى فلودارا و اندوكسان مع العلاج الكميائى COP كعلاج اولى فى مرضى اللوكيميا الليمفاويه المزمنه [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology Summary: Chronic lymphocytic leukemia (CLL) is a neoplastic disease characterized by the accumulation of small mature appearing lymphocytes in the blood , marrow , and lymphoid tissues with the introduction of new therapies and novel combination approaches , the therapeutic goal of CLL has shifted to that of achieving a molecular complete response by eradicating all malignant B cells and therefore , residual disease especially in younger patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2006.Ne.F (Browse shelf(Opens below)) Not for loan 01010110046390000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2006.Ne.F (Browse shelf(Opens below)) Not for loan 01020110046390000

Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology

Chronic lymphocytic leukemia (CLL) is a neoplastic disease characterized by the accumulation of small mature appearing lymphocytes in the blood , marrow , and lymphoid tissues with the introduction of new therapies and novel combination approaches , the therapeutic goal of CLL has shifted to that of achieving a molecular complete response by eradicating all malignant B cells and therefore , residual disease especially in younger patients

Issued also as CD

There are no comments on this title.

to post a comment.